Form 4 for TLSA Tiziana Life Sciences Ltd
Accepted 2026-08-05 16:30:21 ET · period of report 2026-08-03 · accession 0001213900-26-085710 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-08-05 16:30 | 2026-08-03 | TLSA | Elrifi Ivor | CEO | P - Purchase | $1.00 | +667.0K | 4.47M | +18% | +$667.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2026-08-03 | P | A | 667,000 | $1.00 | 4,472,261 | I By trust | — | — |